FDA Modernization Act 3.0
What changed between versions
Removed the provision (old subsection (b)(2)) that allowed the Secretary to make additional changes to the listed CFR sections beyond what was explicitly required. This narrows the rule's scope to only the specific replacements and definition additions now stated in the text.
The requirement to add the 'nonclinical test' definition from section 505(z) of the FDCA to CFR sections 312.3, 314.3, 315.2, and 601.31 was moved from a standalone subsection (c) into subpart (B) of the main rule requirement, making it an explicit part of what the interim final rule must do rather than a separate obligation.
The overall structure was reorganized: old subsections (a), (b), (c), and (d) were consolidated into two subsections (a) and (b). The technical amendment (renumbering section 505(z) to 505(aa)) moved from subsection (d) to subsection (b).